Impaired left ventricular function and myocardial blood flow reserve in patients with long-term type 1 diabetes and no significant coronary artery disease: Associations with protein glycation

Diabetes and Vascular Disease Research

Volumn 11, Issue 2, 2014, Pages 84-91

  Sveen, Kari Anne ^a,b   Nerdrum, Tone ^c   Hanssen, Kristian F ^a,b   Brekke, Magne ^a   Torjesen, Peter A ^a   Strauch, Christopher M ^d   Sell, David R ^d   Monnier, Vincent M ^d   Dahl Jørgensen, Knut ^b,e   Steine, Kjetil ^b,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

advanced glycation end products; Diabetes mellitus; diabetic cardiomyopathy; diastolic dysfunction; HbA1c; myocardial blood flow reserve; type 1

Indexed keywords

ADVANCED GLYCATION END PRODUCTS; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; DIASTOLIC DYSFUNCTION; HBA1C; MYOCARDIAL BLOOD FLOW RESERVE; TYPE 1;

ADULT; AGED; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 1; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE; MIDDLE AGED; TIME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84894416963     PISSN: 14791641     EISSN: 17528984     Source Type: Journal    
DOI: 10.1177/1479164113518805     Document Type: Article

References (31)

1. Grandi AM, Piantanida E, Franzetti I, et al. Effect of glycemic control on left ventricular diastolic function in type 1 diabetes mellitus. Am J Cardiol. 2006; 97: 71-76
2. Shishehbor MH, Hoogwerf BJ, Schoenhagen P, et al. Relation of hemoglobin A1c to left ventricular relaxation in patients with type 1 diabetes mellitus and without overt heart disease. Am J Cardiol. 2003; 91 1514-1517: A9
3. Monnier VM, Vishwanath V, Frank KE, et al. Relation between complications of type I diabetes mellitus and collagen-linked fluorescence. N Engl J Med. 1986; 314: 403-408
4. Berg TJ, Snorgaard O, Faber J, et al. Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes. Diabetes Care. 1999; 22: 1186-1190
5. Schilling JD, Mann DL. Diabetic cardiomyopathy: bench to bedside. Heart Fail Clin. 2012; 8: 619-631
6. Saraiva RM, Duarte DM, Duarte MP, et al. Tissue Doppler imaging identifies asymptomatic normotensive diabetics with diastolic dysfunction and reduced exercise tolerance. Echocardiography. 2005; 22: 561-570
7. Strauer BE, Motz W, Vogt M, et al. Evidence for reduced coronary flow reserve in patients with insulin-dependent diabetes. A possible cause for diabetic heart disease in man. Exp Clin Endocrinol Diabetes. 1997; 105: 15-20
8. Pop-Busui R, Kirkwood I, Schmid H, et al. Sympathetic dysfunction in type 1 diabetes: association with impaired myocardial blood flow reserve and diastolic dysfunction. J Am Coll Cardiol. 2004; 44: 2368-2374
9. Di Carli MF, Janisse J, Grunberger G, et al. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol. 2003; 41: 1387-1393
10. Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, et al. Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study. Br Med J (Clin Res Ed). 1986; 293: 1195-1199
11. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005; 18: 1440-1463
12. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977; 55: 613-618
13. Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr. 2009; 10: 165-193
14. Reisner SA, Lysyansky P, Agmon Y, et al. Global longitudinal strain: a novel index of left ventricular systolic function. J Am Soc Echocardiogr. 2004; 17: 630-633
15. Sicari R, Nihoyannopoulos P, Evangelista A, et al. Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr. 2008; 9: 415-437
16. Malm S, Frigstad S, Helland F, et al. Quantification of resting myocardial blood flow velocity in normal humans using real-time contrast echocardiography. A feasibility study. Cardiovasc Ultrasound. 2005; 3: 16
17. Wei K, Jayaweera AR, Firoozan S, et al. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation. 1998; 97: 473-483
18. Kilhovd BK, Giardino I, Torjesen PA, et al. Increased serum levels of the specific AGE-compound methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes. Metabolism. 2003; 52: 163-167
19. Monnier VM, Sell DR, Strauch C, et al. The association between skin collagen glucosepane and past progression of microvascular and neuropathic complications in type 1 diabetes. J Diabetes Complications. 2013; 27: 141-149
20. Dahl-Jorgensen K. Near-normoglycemia and late diabetic complications. The Oslo Study. Acta Endocrinol Suppl (Copenh). 1987; 284: 1-38
21. Bucala R, Tracey KJ, Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest. 1991; 87: 432-438
22. Nakamura Y, Horii Y, Nishino T, et al. Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus. Am J Pathol. 1993; 143: 1649-1656
23. Van Heerebeek L, Hamdani N, Handoko ML, et al. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation. 2008; 117: 43-51
24. Ju H, Dixon IM. Extracellular matrix and cardiovascular diseases. Can J Cardiol. 1996; 12: 1259-1267
25. Verzijl N, DeGroot J, Thorpe SR, et al. Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem. 2000; 275: 39027-39031
26. Takeda Y, Sakata Y, Mano T, et al. Competing risks of heart failure with preserved ejection fraction in diabetic patients. Eur J Heart Fail. 2011; 13: 664-669
27. Steine K, Larsen JR, Stugaard M, et al. LV systolic impairment in patients with asymptomatic coronary heart disease and type 1 diabetes is related to coronary atherosclerosis, glycaemic control and advanced glycation endproducts. Eur J Heart Fail. 2007; 9: 1044-1050
28. Moir S, Hanekom L, Fang ZY, et al. Relationship between myocardial perfusion and dysfunction in diabetic cardiomyopathy: a study of quantitative contrast echocardiography and strain rate imaging. Heart. 2006; 92: 1414-1419
29. Vogel R, Indermuhle A, Meier P, et al. Quantitative stress echocardiography in coronary artery disease using contrast-based myocardial blood flow measurements: prospective comparison with coronary angiography. Heart. 2009; 95: 377-384
30. Rana O, Byrne CD, Kerr D, et al. Acute hypoglycemia decreases myocardial blood flow reserve in patients with type 1 diabetes mellitus and in healthy humans. Circulation. 2011; 124: 1548-1556
31. Lind M, Bounias I, Olsson M, et al. Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study. Lancet. 2011; 378: 140-146